According to Cardiovascular Systems's latest financial reports the company has a price-to-book ratio of 3.53.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 2.38 | -18.79% |
2021-12-31 | 2.93 | -54.31% |
2020-12-31 | 6.42 | -46.26% |
2019-12-31 | 12.0 | 66.97% |
2018-12-31 | 7.16 | 9.78% |
2017-12-31 | 6.52 | -8.7% |
2016-12-31 | 7.14 | 75% |
2015-12-31 | 4.08 | -36.33% |
2014-12-31 | 6.41 | -2.02% |
2013-12-31 | 6.54 | -27.88% |
2012-12-31 | 9.07 | 13.26% |
2011-12-31 | 8.01 | -25.52% |
2010-12-31 | 10.8 | 258.14% |
2009-12-31 | 3.00 | 401.93% |
2008-12-31 | 0.5983 | -39.82% |
2007-12-31 | 0.9942 | -53.14% |
2006-12-31 | 2.12 | |
2005-12-31 | N/A | |
2004-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.12 | 45.24% | ๐บ๐ธ USA |
Medtronic MDT | 2.04 | -42.24% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 5.51 | 56.26% | ๐บ๐ธ USA |
Merit Medical MMSI | 3.56 | 0.96% | ๐บ๐ธ USA |
LeMaitre Vascular LMAT | 4.92 | 39.60% | ๐บ๐ธ USA |
AngioDynamics ANGO | 0.5795 | -83.56% | ๐บ๐ธ USA |